研究者一覧

髙橋　威洋Takahashi Takehiro

■所属部署名	腫瘍内科
■職名	講師

Last Updated :2025/04/01

Higher systemic exposure to unbound active metabolites of regorafenib is associated with short progression-free survival in colorectal cancer patients, KUBOTA Yutaro;FUJITA Ken-ichi;TAKAHASHI Takehiro;SUNAKAWA Yu;ISHIDA Hiroo;HAMADA Kazuyuki;ICHIKAWA Wataru;TSUNODA Takuya;SHIMADA Kazuhiro;MASUO Yusuke;KATO Yukio;SASAKI Yasutsuna, Clin Pharmacol Ther, 108(3):586 - 595, 2020年09月, 原著, 査読あり, DOI:10.1002/cpt.1810

Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil, SEKIDO Masae;FUJITA Ken-ichi;KUBOTA Yutaro;ISHIDA Hiroo;TAKAHASHI Takehiro;OHKUMA Ryotaro;TSUNODA Takuya;ISHIKAWA Fumihiro;SHIBANUMA Motoko;SASAKI Yasutsuna, Cancer Chemother Pharmacol, 83(6):1127 - 1135, 2019年06月, 原著, 査読あり

Lack of correlation between the costs of anticancer drugs and clinical benefits in Japan., SATOH Etsuko;SASAKI Yasutsuna;OHKUMA Ryotaro;TAKAHASHI Takehiro;KUBOTA Yutaro;ISHIDA Hiroo;HAMADA Kazuyuki;KIUCHI Yuji;TSUNODA Takuya, Cancer Sci, 109(12):3896 - 3901, 2018年12月, 原著

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer., SUNAKAWA Yu;MOGUSHI Kaoru;LENZ Heinz-Josef;ZHANG Wu;TSUJI Akihito;TAKAHASHI Takehiro;DENDA Tadamichi;SHIMADA Ken;KOCHI Mitsugu;NAKAMURA Masato;KOTAKA Masahiro;SEGAWA Yoshihiko;TANIOKA Hiroaki;NEGORO Yuji;MORAN Miriana;ASTROW Stephanie H;HSIANG Jack;STEPHENS Craig;FUJII Masashi;ICHIKAWA Wataru, Mol Cancer Ther, 17(12):2788 - 2795, 2018年12月, 原著, 査読あり

Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer., SUNAKAWA Yu;YANG Dongyun;CAO Shu;ZHANG Wu;MORAN Miriana;ASTROW Stephanie H;HSIANG Jack;STEPHENS Craig;TSUJI Akihito;TAKAHASHI Takehiro;TANIOKA Hiroaki;NEGORO Yuji;TAKAGANE Akinori;TANI Satoshi;YAMAGUCHI Tatsuro;ETO Tetsuya;FUJII Masashi;ICHIKAWA Wataru;LENZ Heinz-Josef, Clin Colorectal Cancer, 17(4):e741 - e749, 2018年12月, 原著, 査読あり

Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer., SUNAKAWA Yu;YANG Dongyun;MORAN Miriana;ASTROW Stephanie H;TSUJI Akihito;STEPHENS Craig;ZHANG Wu;CAO Shu;TAKAHASHI Takehiro;DENDA Tadamichi;SHIMADA Ken;KOCHI Mitsugu;NAKAMURA Masato;KOTAKA Masahito;SEGAWA Yoshihiko;MASUISHI Toshiki;TAKEUCHI Masahiro;FUJII Masashi;NAKAJIMA Toshifusa;ICHIKAWA Wataru;LENZ Heinz-Josef, Cancer Biol Ther, 17(7):751 - 759, 2016年07月, 原著, 査読あり

Comparison of cancer drug approval by PMDA in the US, SATOH Etsuko;ISHIDA Hiroo;TAKAHASHI Takehiro;KUBOTA Yutaro;KUSUMOTO Sojiro;KISHINO Yasunari;TOJO Masayuki;HAMADA Kazuyuki;SASAKI Yasutsuna, 第14回日本臨床腫瘍学会学術集会, 2016年07月29日, 神戸